Gothenburg, Sweden

Jonas Faijerson Saijo

This inventor holds 1 USPTO granted patent. Top assignee: Cereno Scientific Ab. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonas Faijerson Saijo. Retrieved from https://idiyas.com/inventor/jonas-faijerson-saijo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jonas Faijerson Saijo

Introduction

Jonas Faijerson Saijo is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative formulations. His work focuses on enhancing the efficacy of medications through advanced delivery systems.

Latest Patents

Saijo holds a patent for "Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof." This patent describes a pharmaceutical formulation that includes valproic acid and/or its pharmaceutically acceptable salts, along with one or more secondary acids. The formulation may also contain various pharmaceutically acceptable excipients, which enhance its effectiveness.

Career Highlights

Jonas is associated with Cereno Scientific AB, a company dedicated to developing innovative therapies. His work at Cereno Scientific has positioned him as a key player in the pharmaceutical industry, contributing to advancements in drug formulation and delivery.

Collaborations

Some of his notable coworkers include Niklas Bergh and Sverker Jern. Their collaboration has fostered a productive environment for innovation and research within the company.

Conclusion

Jonas Faijerson Saijo's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare through innovation. His work continues to influence the development of effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…